Early escharectomy stands as a cornerstone in the treatment of deep burns. While effective, the procedure is demanding in terms of personnel, and traumatic: blood losses can easily reach 100 ml per % TBSA excised with profound effects on the patient especially if unstable. The recently introduced enzymatic debridement with NexoBridTM (NXB) has been stated to be effective, fast, selective, safe, and to reduce the surgical burden of the patient. Aim of the study: to investigate the effectiveness of NXB in providing a safe and effective early escharectomy with limited blood loss in burns requiring surgical debridement.
Enzymatic debridement as a non-traumatic alternative for safe early escharectomy
Tocco-Tussardi I;
2016-01-01
Abstract
Early escharectomy stands as a cornerstone in the treatment of deep burns. While effective, the procedure is demanding in terms of personnel, and traumatic: blood losses can easily reach 100 ml per % TBSA excised with profound effects on the patient especially if unstable. The recently introduced enzymatic debridement with NexoBridTM (NXB) has been stated to be effective, fast, selective, safe, and to reduce the surgical burden of the patient. Aim of the study: to investigate the effectiveness of NXB in providing a safe and effective early escharectomy with limited blood loss in burns requiring surgical debridement.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
